Follow US:
The School of Medicine has lessons to share after several months of in-person classes with no documented cases of COVID-19 transmission
UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut
Researchers conducted focus groups of UC Riverside faculty, staff, and students
It's the time of year when Inland Southern California becomes a 27,000-square-mile skillet. We asked UC Riverside physicians how to stay safe and hydrated.
UC Riverside experts share their thoughts
UC Riverside mouse study suggests inflammation could play key role in progression to asthma
The California Wellness Foundation has awarded the School of Medicine a $450,000 grant
UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care
Study by UC Riverside researchers will examine impacts of remote learning on families with children in grades K-12
PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs
The Regents of the University of California have given final approval for the construction of the School of Medicine’s new Education Building II at UC Riverside. The vote, which approved the final design, the full budget, and the California Environmental Quality Act, or CEQA, findings, took place during the Regents’...
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
C OVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside...
UC Riverside-led study examined the effects of the medication risperidone on brain metabolism in stuttering
UC Riverside-led mouse study stresses MS treatment should be started early
UC Riverside epidemiologist answers this and other questions in Q&A
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
A UC Riverside-led study, funded by Merck, is set to find out
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
